Predict your next investment

Private Equity

See what CB Insights has to offer

Investments

15

Portfolio Exits

2

About Qingsong Capital

Qingsong Capital is a private equity firm based in China.

Qingsong Capital Headquarter Location

Beijing, Beijing,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Qingsong Capital Investments

15 Investments

Qingsong Capital has made 15 investments. Their latest investment was in Ionova Life Science as part of their Series B on August 8, 2021.

CBI Logo

Qingsong Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/23/2021

Series B

Ionova Life Science

$100M

Yes

8

6/3/2021

Series B

Stemirna Therapeutics

$200M

Yes

8

6/2/2021

Series A - IV

Tavotek Biotherapeutics

Yes

1

3/16/2021

Series A - III

Subscribe to see more

$99M

Subscribe to see more

10

1/19/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/23/2021

6/3/2021

6/2/2021

3/16/2021

1/19/2021

Round

Series B

Series B

Series A - IV

Series A - III

Series B

Company

Ionova Life Science

Stemirna Therapeutics

Tavotek Biotherapeutics

Subscribe to see more

Subscribe to see more

Amount

$100M

$200M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

8

8

1

10

10

Qingsong Capital Portfolio Exits

2 Portfolio Exits

Qingsong Capital has 2 portfolio exits. Their latest portfolio exit was Sino Biological on August 16, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/16/2021

IPO

$991

2

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

8/16/2021

00/00/0000

Exit

IPO

Subscribe to see more

Companies

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Sources

2

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.